Table of Contents Table of Contents
Previous Page  8 / 236 Next Page
Information
Show Menu
Previous Page 8 / 236 Next Page
Page Background

This 2016 Section 5 Home Study Course includes discussion of off-label uses of the following drugs and

devices which has not been approved by the United States Food and Drug Administration:

Name of Drug(s) or Device(s)

Nature of Off-label Discussion

Theophylline methylpropyl paraben

Used to try to improve taste and smell

Oral corticosteroids

Use in chronic rhinosinusitis

Macrolide antibiotics

Use in chronic rhinosinusitis

Topical antibiotic washes

Use in acute bacterial rhinosinusitis

Topical budesonide washes

Use in chronic rhinosinusitis

Oral antibiotics

Use in acute bacterial rhinosinusitis

Disclaimer

The information contained in this activity represents the views of those who created it and does not

necessarily represent the official view or recommendations of the American Academy of Otolaryngology –

Head and Neck Surgery Foundation.

October 10, 2016:

Suggested

Section 5 Exam submission deadline; course closed

August 4, 2017.

EVIDENCE BASED MEDICINE

The AAO-HNSF Education Advisory Committee approved the assignment of the appropriate level of

evidence to support each clinical and/or scientific journal reference used to authenticate a continuing

medical education activity. Noted at the end of each reference, the level of evidence is displayed in this

format:

[EBM Level 3]

.

Oxford Centre for Evidence-based Medicine Levels of Evidence (May 2001)

Level 1

Randomized

1

controlled trials

2

or a systematic review

3

(meta-analysis

4

) of randomized

controlled trials

5

.

Level 2

Prospective (cohort

6

or outcomes) study

7

with an internal control group or a systematic

review of prospective, controlled trials.

Level 3

Retrospective (case-control

8

) study

9

with an internal control group or a systematic review of

retrospective, controlled trials.

Level 4

Case series

10

without an internal control group (retrospective reviews; uncontrolled cohort or

outcome studies).

Level 5

Expert opinion without explicit critical appraisal, or recommendation based on

physiology/bench research.

Two

additional ratings

to be used for articles that do not fall into the above scale. Articles that are informational only

can be rated N/A , and articles that are a review of an article can be rated as Review. All definitions adapted from

Glossary of Terms, Evidence Based Emergency Medicine at New York Academy of Medicine a

t www.ebem.org .

1

A technique which gives every patient an equal chance of being assigned to any particular arm of a controlled clinical trial.

2

Any study which compares two groups by virtue of different therapies or exposures fulfills this definition.

3

A formal review of a focused clinical question based on a comprehensive search strategy and structure critical appraisal.

4

A review of a focused clinical question following rigorous methodological criteria and employing statistical techniques to

combine data from independently performed studies on that question.

5

A controlled clinical trial in which the study groups are created through randomizations.

6

This design follows a group of patients, called a “cohort”, over time to determine general outcomes as well as outcomes of

different subgroups.

7

Any study done forward in time. This is particularly important in studies on therapy, prognosis or harm, where retrospective

studies make hidden biases very likely.

8

This might be considered a randomized controlled trial played backwards. People who get sick or have a bad outcome are

identified and “matched” with people who did better. Then, the effects of the therapy or harmful exposure which might have

been administered at the start of the trial are evaluated.

9

Any study in which the outcomes have already occurred before the study has begun.

10

This includes single case reports and published case series.